| abstract |
Disclosed herein are safer resinotoxin (RTX) formulations for intrathecal, intraganglionic, intraarticular and pericardial administration. More specifically, an ethanol-free formulation of RTX is disclosed that includes a solubilizing component, a monosaccharide or sugar alcohol, a salt buffer, and RTX, and has a narrow pH range and specific gravity. |